Stock Report

All about this stock under one free report Last Updated: 01-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Farmax India Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: FARMAXIND | BSE: 590094

₹0.05

₹0.00 (0.00%)

As on 02-Jul-2018IST

Market cap

info icon

₹5 Cr

Revenue (TTM)

info icon

₹4 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -94.14 -97.40 -68.68 -26.36 -39.35
EBIT -21.94 84.07 71.91 21.28 -219.16
Net Profit -21.75 84.07 31.64 25.47 -204.48
EPS -21.77 84.05 31.74 20.77 -15.45
Book Value -- -- -17.26 9.42 -162.70
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-17Mar-16Mar-15
EBIT-Margin info -47.83-39.76-63.97-61.32-18.19
Net Margin info -43.40-84.68-62.40-58.60-9.21
Return on equity info 0.00-62.420.000.000.00
Return on Capital info -17.26-45.93-11.69-32.74-7.37
Return on Assets info -13.00-44.08-8.56-24.89-5.55
Debt to Equity (x) info -----2.19-2.56-6.50

Profitability

View Detailed Peer Comparison

ROCE

-11.69

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-11.69
-32.74
-7.37
-12.10
-165.75
Peer Median
--
--
--
--
--
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
--
--
--
--
-312.08
Peer Median
--
--
--
--
--
ROA

-8.56

--

Profit after tax / Average Total assets * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-8.56
-24.89
-5.55
-27.88
-153.51
Peer Median
--
--
--
--
--
EBIT Margin

-63.97

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-63.97
-61.32
-18.19
-17.49
-37.82
Peer Median
--
--
--
--
--
Net Margin

-62.40

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-62.40
-58.60
-9.21
-49.73
-243.45
Peer Median
--
--
--
--
--
Cash Profit Margin

-32.95

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-32.95
-49.87
0.31
-39.65
-240.28
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-73.29

--

Year on year growth in net sales

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-73.29
-21.98
20.83
-66.48
-43.21
Peer Median
--
--
--
--
--
EBIT Growth

72.13

--

Year on year growth in operating profit (EBIT)

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
72.13
-163.00
-25.67
84.50
-3,222.07
Peer Median
--
--
--
--
--
Net Profit Growth

71.77

--

Year on year growth in profit after tax

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
71.77
-365.53
76.24
93.05
-6,823.07
Peer Median
--
--
--
--
--
EPS Growth

71.76

--

Year on year growth in earnings per share

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
71.76
-365.90
81.86
93.05
-4,279.49
Peer Median
--
--
--
--
--
Book Value Growth

-17.26

--

Year on year growth in book value per share

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-17.26
-153.60
69.65
-72.89
-112.84
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-2.19

--

Total debt / Net worth

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-2.19
-2.56
-6.50
-2.00
-2.94
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-3.43

--

(Short term borrowings / Net worth)

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-3.43
-4.49
50.00
-3.00
-6.02
Peer Median
--
--
--
--
--
Current Ratio

0.20

--

Current Assets / Current Liabilities and Provisions

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
0.20
0.24
0.44
0.08
0.08
Peer Median
--
--
--
--
--
Quick Ratio

0.19

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
0.19
0.19
0.24
0.00
0.01
Peer Median
--
--
--
--
--
Interest Coverage

-3,067.22

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-3,067.22
-1,481.02
-33.96
-0.43
-25.74
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

142.64

--

Debtors outstanding / Net Sales * 100

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
142.64
37.75
32.97
1.00
0.30
Peer Median
--
--
--
--
--
Asset Turnover

0.14

--

Sales / Average Total Assets

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
0.14
0.42
0.56
0.55
0.63
Peer Median
--
--
--
--
--
Receivable days

518.25

--

Average Debtors / Sales * 365

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
518.25
145.98
61.63
3.46
60.05
Peer Median
--
--
--
--
--
Inventory Days

88.24

--

Average Inventory / Sales * 365

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
88.24
119.96
105.84
64.89
62.81
Peer Median
--
--
--
--
--
Payable days

88.67

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
88.67
32.33
36.93
22.34
3.69
Peer Median
--
--
--
--
--
Cash Conversion Cycle

517.82

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
517.82
233.60
130.55
46.01
119.17
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
--
--
--
--
--
Peer Median
--
--
--
--
--
Price / Book Value

-0.26

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-0.26
-0.53
-4.91
-0.77
-1.49
Peer Median
--
--
--
--
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
--
--
--
--
--
Peer Median
--
--
--
--
--
EV/EBITDA

-31.73

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
-31.73
-6.03
572.78
-79.23
-3.18
Peer Median
--
--
--
--
--
Market Cap

5

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-17
Mar-16
Mar-15
Mar-14
Mar-13
Farmax India
5
9
31
16
18
Peer Median
--
--
--
--
--
loading...
loading...
loading...
loading...
loading...